Canada markets close in 36 minutes

Codexis, Inc. (CDXS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.41-0.29 (-4.40%)
As of 03:24PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close6.70
Open6.55
Bid6.39 x 800
Ask6.40 x 900
Day's Range6.33 - 6.70
52 Week Range4.21 - 22.22
Volume287,665
Avg. Volume828,865
Market Cap420.725M
Beta (5Y Monthly)1.48
PE Ratio (TTM)N/A
EPS (TTM)-0.32
Earnings DateFeb 22, 2023 - Feb 27, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.25
  • Simply Wall St.

    Codexis (NASDAQ:CDXS) shareholders have endured a 68% loss from investing in the stock a year ago

    Over the last month the Codexis, Inc. ( NASDAQ:CDXS ) has been much stronger than before, rebounding by 41%. But that's...

  • GlobeNewswire

    Codexis Announces Appointment of Sri Ryali as Chief Financial Officer

    REDWOOD CITY, Calif., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of Sri Ryali as Chief Financial Officer effective immediately. Mr. Ryali brings 20 years of finance and commercial experience in life sciences to Codexis. In this role, Mr. Ryali will lead all aspects of the Company’s financial operations and will report directly to Dr. Stephen Dilly, President and Chief Executive Officer of Codexis. “I am ex

  • GlobeNewswire

    Codexis Announces Appointment of H. Stewart Parker to Board of Directors

    REDWOOD CITY, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of H. Stewart Parker to its Board of Directors. “Stewart’s deep expertise in gene therapy and demonstrated track record of executive leadership within the biopharmaceutical industry make her a compelling addition as we seek to continue to strengthen the diversity of our Board with a breadth of professional experience, educational background,